Brief: DxVx plans to make a license-in agreement of OVM-200 and conduct clinical trials in Asia
24/11/2023 14:05
Nov 24 (Reuters) - Dx & Vx Co Ltd 180400.KQ :
* DXVX, PLANS TO MAKE A LICENSE-IN AGREEMENT OF OVM-200 AND
CONDUCT CLINICAL TRIALS IN ASIA
* DX & VX CO LTD: PLANS TO PROCEED ITS OWN CLINICAL TRIALS
OF
OVM-200 IN ASIA, INCLUDING KOREA AND CHINA
Source text for Eikon: ID:nPn2Mf4VZa
Further company coverage: 180400.KQ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dx & Vx
See all newsBrief: Coree Announces Discovery Of Microbiome Biomarkers Specific To Diabetes And Obesity Patients
Development And License Agreement For Mrna Cancer Vaccine With U.S. Biotech Company
Brief: Dx&Vx Accelerates Development of Universal COVID-19 Vaccine
Slovenia's parliament commission rejects former prime minister as central bank governor
Brief: Dx & Vx Co Ltd Wins 10.3 Billion Won Order